Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Term Ocular Safety Assessment of High Dose Omega-3 Supplementation for Age-Related Macular Degeneration.

NCT01258335 is registered in ClinicalTrials.gov with Mid Atlantic Retina as lead sponsor.

NCT NCT01258335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01258335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Term Ocular Safety Assessment of High Dose Omega-3 Supplementation for Age-Related Macular Degeneration.
Lead sponsor
Mid Atlantic Retina
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2008
Completion date
November 30, 2010
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aged macular degeneration